Anatara Financial Statements From 2010 to 2024

Stocks . Australia . 
Stock . Anatara Lifesciences
ANR Stock   0.06  0.00  0.00%   
Anatara Lifesciences financial statements provide useful quarterly and yearly information to potential Anatara Lifesciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Anatara Lifesciences financial statements helps investors assess Anatara Lifesciences' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Anatara Lifesciences' valuation are summarized below:
Gross Profit
-1.6 M
Market Capitalization
12.1 M
Enterprise Value Revenue
2.1812
Revenue
-123.2 K
Earnings Share
(0.01)
There are currently eighty fundamental signals for Anatara Lifesciences that can be evaluated and compared over time across rivals. All traders should validate Anatara Lifesciences' prevailing fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction.

Anatara Lifesciences Total Revenue

0.0

Check Anatara Lifesciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Anatara Lifesciences' main balance sheet or income statement drivers, such as Interest Expense of 2.9 K, Selling General Administrative of 1.6 M or Total Revenue of 0.0, as well as many indicators such as . Anatara financial statements analysis is a perfect complement when working with Anatara Lifesciences Valuation or Volatility modules.
  
This module can also supplement various Anatara Lifesciences Technical models . Check out the analysis of Anatara Lifesciences Correlation against competitors.

Anatara Lifesciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.6 M1.7 M4.7 M
Very volatile
Total Current Liabilities369 K304.2 K337.7 K
Slightly volatile
Cash933 K982.1 K2.4 M
Pretty Stable
Net Receivables518.6 K671.1 K474.6 K
Slightly volatile
Total Liabilities433.2 K306.8 K396.5 K
Slightly volatile
Common Stock14.6 M23.2 M13.4 M
Slightly volatile
Other Current Assets544.3 K688.5 K626.3 K
Pretty Stable
Short and Long Term Debt Total114.3 K59.2 K132.2 K
Slightly volatile
Other Current Liabilities53.3 K56.1 K174.9 K
Slightly volatile
Accounts Payable149.2 K248 K119.4 K
Slightly volatile
Cash And Short Term Investments933 K982.1 K4 M
Pretty Stable
Common Stock Shares Outstanding157.5 M150 M60.3 M
Slightly volatile
Liabilities And Stockholders Equity1.6 M1.7 M4.7 M
Very volatile
Total Current Assets1.6 M1.7 M4.6 M
Very volatile
Net Tangible Assets790.5 K832.1 K4 M
Pretty Stable
Common Stock Total Equity16 M19.6 M14.3 M
Slightly volatile
Property Plant And Equipment Net75479427.2 K
Very volatile
Non Current Assets Total75479428.1 K
Very volatile
Property Plant And Equipment Gross75479428.7 K
Very volatile
Property Plant Equipment3.6 K3.7 K27.6 K
Very volatile
Net Invested Capital1.3 M1.4 M7.4 M
Slightly volatile
Cash And Equivalents7 M7.9 M8.6 M
Slightly volatile
Net Working Capital1.3 M1.4 M7.4 M
Slightly volatile
Other Liabilities569598345 K
Slightly volatile
Capital Stock21.7 M23.2 M18.4 M
Slightly volatile
Capital Lease Obligations58.3 K59.2 K75.2 K
Slightly volatile

Anatara Lifesciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative1.6 M1.4 M1.5 M
Slightly volatile
Research Development781 K748.9 K677 K
Slightly volatile
Cost Of Revenue786.4 K748.9 K421.5 K
Pretty Stable
Depreciation And Amortization2.3 K2.5 K225.6 K
Slightly volatile
Selling And Marketing Expenses21.8523.0222.6 K
Slightly volatile
Other Operating Expenses1.4 M1.5 M2.3 M
Slightly volatile
Total Operating Expenses674.7 K710.2 K2 M
Slightly volatile
Net Interest Income7.5 K7.9 K191.3 K
Slightly volatile
Interest Income7.5 K7.9 K191.7 K
Slightly volatile
Reconciled Depreciation2.3 K2.5 K15.9 K
Slightly volatile

Anatara Lifesciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
End Period Cash Flow1.8 M982.1 K2.1 M
Very volatile
Begin Period Cash Flow333.6 K351.2 K1.9 M
Pretty Stable
Depreciation2.3 K2.5 K15.2 K
Pretty Stable
Stock Based Compensation27.2 K28.6 K176 K
Slightly volatile
Issuance Of Capital Stock1.8 M2 M2.7 M
Slightly volatile

Anatara Fundamental Market Drivers

Cash And Short Term Investments982.1 K

About Anatara Lifesciences Financial Statements

Anatara Lifesciences shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Anatara Lifesciences investors may analyze each financial statement separately, they are all interrelated. The changes in Anatara Lifesciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Anatara Lifesciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue-23.8 K-24.9 K
Cost Of Revenue748.9 K786.4 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Anatara Stock Analysis

When running Anatara Lifesciences' price analysis, check to measure Anatara Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anatara Lifesciences is operating at the current time. Most of Anatara Lifesciences' value examination focuses on studying past and present price action to predict the probability of Anatara Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anatara Lifesciences' price. Additionally, you may evaluate how the addition of Anatara Lifesciences to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY